Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:05:01 EDT Wed 12 Aug 2026
Enter Symbol
or Name
USA
CA



Q:RGEN - REPLIGEN CORP - https://www.repligen.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
RGEN - Q2.7165.73·172.663.4165.70+0.930.6833.9137,17513,411164.42  166.955  162.36175.57  100.9916:19:20Jul 2815 min RT 2¢

Recent Trades - Last 10 of 13411
Time ETExPriceChangeVolume
16:19:20Q169.004.231
16:16:42Q169.004.231
16:15:00Q165.700.931
16:10:04Q165.700.931
16:10:04Q165.700.931
16:10:04Q165.700.931
16:10:04Q165.700.931
16:04:29Q165.700.931
16:04:27Q165.700.931
16:04:23Q165.700.931

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-07-28 07:00U:RGENNews ReleaseRepligen Reports Second Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
2026-07-22 06:00U:RGENNews ReleaseRepligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
2026-07-15 07:30U:RGENNews ReleaseRepligen to Report Second Quarter 2026 Financial Results
2026-05-22 07:30U:RGENNews ReleaseRepligen Corporation to Present at William Blair 46th Annual Growth Stock Conference
2026-05-20 07:30U:RGENNews ReleaseRepligen Announces Publication of the Company's 2025 Corporate Sustainability Report
2026-05-07 07:30U:RGENNews ReleaseRepligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference
2026-05-05 07:00U:RGENNews ReleaseRepligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance
2026-04-22 07:30U:RGENNews ReleaseRepligen to Report First Quarter 2026 Financial Results
2026-04-17 07:30U:RGENNews ReleaseRepligen Opens European Training & Innovation Center in Breda, Expanding Global Customer Support Network
2026-03-05 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming March Conferences
2026-02-24 07:30U:RGENNews ReleaseRepligen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
2026-02-10 07:30U:RGENNews ReleaseRepligen to Report Fourth Quarter and Full Year 2025 Financial Results
2026-01-06 07:30U:RGENNews ReleaseRepligen Executive Chair Tony Hunt to Retire; Dr. Martin D. Madaus Elected Chair
2025-12-18 07:30U:RGENNews ReleaseRepligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference
2025-12-16 07:30U:RGENNews ReleaseRepligen Introduces Next-Generation Chromatography Resins to Advance New Modality Workflows
2025-11-26 07:30U:RGENNews ReleaseRepligen Corporation to Present at Evercore Healthcare Conference
2025-11-04 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming November Conferences
2025-10-28 07:30U:RGENNews ReleaseRepligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
2025-10-15 07:30U:RGENNews ReleaseRepligen to Report Third Quarter 2025 Financial Results
2025-08-22 07:30U:RGENNews ReleaseRepligen Corporation to Present at Upcoming September Conferences